Literature DB >> 30188973

Impaired Proinflammatory Response in Stringently Defined Otitis-prone Children During Viral Upper Respiratory Infections.

Dabin Ren1, Qingfu Xu1, Anthony L Almudevar2, Michael E Pichichero1.   

Abstract

BACKGROUND: Viral upper respiratory infections (URIs) are common and often precipitate acute otitis media (AOM), caused by bacterial otopathogens, in young children. Acute inflammatory responses initiated in the early phase of viral URI contribute to preventing the development of AOM. Stringently-defined otitis-prone (sOP) children are susceptible to recurrent AOM.
METHODS: We assessed proinflammatory cytokine and chemokine levels in the nasopharynxes during viral URIs, and examined the different nasopharyngeal responses between viral URI events and the following AOM episodes in both sOP and non-otitis-prone (NOP) children.
RESULTS: The sOP children exhibited significantly more AOM episodes per child (8.86-fold higher), viral URIs (P < .0001), and viral URIs followed by AOMs (P < .0001) than the NOP children. The sOP children had lower nasal proinflammatory levels of interleukin (IL)-6 (P = .05), IL-10 (P = .001), tumor necrosis factor (TNF)-α (P = .004), and regulated on activation, normal T-cell-expressed and -secreted (RANTES; P = .002) than NOP children during viral URIs. NOP children had higher levels of IL-6 (P = .02), IL-10 (P = .02), interferon-γ (P = .003), TNF-α (P = .006), IL-1β (P = .022), monocyte chemoattractant protein 1 (P = .028), RANTES (P = .005), IL-2 (P = .002), and IL-17 (P = .007) during viral URIs versus AOMs following the URIs, when compared to sOP children.
CONCLUSIONS: We conclude that sOP children have more frequent viral URIs than NOP children, due to deficient antiviral nasopharyngeal proinflammatory cytokine and chemokine responses.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  acute otitis media; chemokine; cytokine; innate immune response; nasopharyngeal colonization

Mesh:

Substances:

Year:  2019        PMID: 30188973      PMCID: PMC6481992          DOI: 10.1093/cid/ciy750

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  26 in total

Review 1.  Ten-Year Study of the Stringently Defined Otitis-prone Child in Rochester, NY.

Authors:  Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2016-09       Impact factor: 2.129

2.  Reduced serum IgG responses to pneumococcal antigens in otitis-prone children may be due to poor memory B-cell generation.

Authors:  Sharad K Sharma; Janet R Casey; Michael E Pichichero
Journal:  J Infect Dis       Date:  2012-03-01       Impact factor: 5.226

Review 3.  The inflammatory response triggered by Influenza virus: a two edged sword.

Authors:  Luciana P Tavares; Mauro M Teixeira; Cristiana C Garcia
Journal:  Inflamm Res       Date:  2016-10-15       Impact factor: 4.575

4.  Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children.

Authors:  Ravinder Kaur; Janet R Casey; Michael E Pichichero
Journal:  Vaccine       Date:  2010-12-01       Impact factor: 3.641

Review 5.  Virus-induced neutrophil dysfunction: role in the pathogenesis of bacterial infections.

Authors:  J S Abramson; J G Wheeler
Journal:  Pediatr Infect Dis J       Date:  1994-07       Impact factor: 2.129

6.  Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection.

Authors:  Melinda M Pettigrew; Janneane F Gent; Richard B Pyles; Aaron L Miller; Johanna Nokso-Koivisto; Tasnee Chonmaitree
Journal:  J Clin Microbiol       Date:  2011-09-07       Impact factor: 5.948

7.  New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.

Authors:  Janet R Casey; Diana G Adlowitz; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2010-04       Impact factor: 2.129

Review 8.  Importance of respiratory viruses in acute otitis media.

Authors:  Terho Heikkinen; Tasnee Chonmaitree
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

Review 9.  Viral upper respiratory tract infections in young children with emphasis on acute otitis media.

Authors:  Johanna Nokso-Koivisto; Tapani Hovi; Anne Pitkäranta
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2006-03-27       Impact factor: 1.675

Review 10.  Innate immune response to viral infection of the lungs.

Authors:  Hayley See; Peter Wark
Journal:  Paediatr Respir Rev       Date:  2008-10-15       Impact factor: 2.726

View more
  5 in total

1.  Comparison of specific in-vitro virulence gene expression and innate host response in locally invasive vs colonizer strains of Streptococcus pneumoniae.

Authors:  Naoko Fuji; Michael E Pichichero; Ravinder Kaur
Journal:  Med Microbiol Immunol       Date:  2021-03-22       Impact factor: 3.402

Review 2.  Immunologic dysfunction contributes to the otitis prone condition.

Authors:  Michael E Pichichero
Journal:  J Infect       Date:  2020-03-20       Impact factor: 6.072

3.  Pneumonia, Sinusitis, Influenza and Other Respiratory Illnesses in Acute Otitis Media-Prone Children.

Authors:  Michael E Pichichero; Timothy J Chapman; Peter Bajorski
Journal:  Pediatr Infect Dis J       Date:  2021-11-01       Impact factor: 3.806

4.  Nasopharyngeal colonization with pathobionts is associated with susceptibility to respiratory illnesses in young children.

Authors:  Timothy J Chapman; Matthew C Morris; Lei Xu; Michael E Pichichero
Journal:  PLoS One       Date:  2020-12-11       Impact factor: 3.240

5.  Nasopharyngeal microbiome composition associated with Streptococcus pneumoniae colonization suggests a protective role of Corynebacterium in young children.

Authors:  Lei Xu; Joshua Earl; Michael E Pichichero
Journal:  PLoS One       Date:  2021-09-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.